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INTRODUCTION
Cardiac implantable electronic devices (CIEDs) are an essential 
part of cardiologic treatment in high-risk patients with a wide 
range of structural or functional heart diseases [1,2]. Over the 
last few decades, numerous procedural changes have been made 
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in pacemaker implantation, mostly attributable to technological 
advancements throughout multiple generations of the devices 
[3]. The size of the pulse generators has also decreased over 
time, making it possible, most notably in pediatric patients, to 
replace abdominal implantation of an epicardial pacemaker with 
an endocardial device in the prepectoral or subpectoral space.
The clinical use of CIEDs has expanded to include not only 
middle-age patients with chronic conditions, but also younger 
patients predisposed to sudden cardiac death. However, several 
problems have arisen with conventional subcutaneous device 
insertion in the subclavian area, most notably the conspicuous 
contour of the pacemaker in the subcutaneous pocket of the an-
terior chest and/or an often unsightly surgical scar (Fig. 1) [4]. 
With this problem in mind, a collaborative team of cardiolo-
gists and plastic surgeons in our institution developed a tech-
nique for the subpectoral placement of CIEDs in young female 
patients via a transaxillary approach. This transaxillary approach 
has been frequently utilized in augmentation mammoplasty to 
hide visible operative scars in the axillary fold, and therefore our 
procedure can be deemed an extension of a familiar surgical ap-
proach for a different purpose. We present our experience with 
this procedure in 10 young female patients, including 1 patient 
who received augmentation mammoplasty together with CIED 
placement.
METHODS
Patients
From July 2012 to December 2015, subpectoral CIED place-
ment via the transaxillary approach was performed in 10 young 
Patient 
no.
Age 
(yr)
Height 
(cm)
Weight 
(kg)
BMI 
(kg/m2)
Symptom (s) Indication Device
Model, company, and 
country
Follow-up 
(wk)
1 38 151.6 53.5 23.28 Palpitation, chest discomfort Sick sinus syndrome Pacemaker Evia, Biotronik, Germany 214.4
2 29 166 55 19.96 Sudden cardiac arrest Ventricular fibrillation ICD Incepta ICD, Boston Scientific, 
United States
130.4
3 34 155 51 21.09 Syncope Dilated cardiomyopathy ICD Ellipse DR, St. Jude Medical, 
United States
126.0
4 16 162 49 18.67 Sudden cardiac arrest Dilated cardiomyopathy ICD Ellipse DR, St. Jude Medical, 
United States
76.0
5 22 151 51.9 22.49 Dizziness Chemotherapy-induced 
dilated cardiomyopathy
CRT-D VivaQuad XT CRT-D, Medtronic, 
Ireland
65.4
6 37 154 48 20.24 Syncope High-degree atrioventricular 
block
Pacemaker Accolade EL, Boston Scientific, 
United States
59.1
7 18 160 48.3 18.75 Syncope Sick sinus syndrome Pacemaker Accolade EL, Boston Scientific, 
United States
57.4
8 25 153 43 18.37 Syncope Hypertrophic cardiomyopathy ICD Evera MRI XT DR, Medtronic, 
Ireland
32.4
9 20 162.1 53 20.17 Dyspnea, dizziness High-degree atrioventricular 
block
Pacemaker Advisa DR MRI, Medtronic, 
Ireland
36.3
10a) 20 161 45.2 17.44 Dyspnea Dilated cardiomyopathy ICD Ellipse DR, St. Jude Medical, 
United States
84.1
Mean 25.9 157.6 49.8 20.05 - - - 88.2
   CIED, cardiac implantable electronic device; BMI, body mass index; ICD, implantable cardioverter-defibrillator; CRT-D, cardiac resynchronization therapy defibrillator. 
  a)A patient who received concomitant augmentation mammoplasty together with CIED placement.
Table 1. Patient demographics, cardiologic indications for CIED implantation with device information, and postoperative 
follow-up periods
Conspicuous scarring and disfiguring bulging often result from the 
conventional subcutaneous insertion of cardiac implantable elec-
tronic devices in the subclavian area.
Fig. 1. Cardiac device in a conventional subclavian pocket
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female patients who were referred from a group of 3 cardiolo-
gists at our institution (Table 1).
All subjects were young and lean female patients with a mean 
age of 25.9 years (range, 16–38 years) and a mean body mass in-
dex (BMI) of 20.1 kg/m2 (range, 17.44–23.28 kg/m2). The 
mean postoperative follow-up period was 88.2 weeks.
The patients had been diagnosed with a range of anatomical 
and functional cardiac abnormalities. Five patients had been di-
agnosed with various types of cardiomyopathy, of whom 3 had 
dilated cardiomyopathy, 1 had chemotherapy-induced cardio-
myopathy, and 1 patient had hypertrophic cardiomyopathy. 
Three patients had symptomatic sick sinus syndrome. Two pa-
tients had high-degree atrioventricular block, and 1 patient had 
ventricular fibrillation.
All patients were highly concerned with any noticeable physi-
cal changes on their chest following the CIED insertion, and 
they wanted any surgical scar to be concealed as much as possi-
ble. One patient with dilated cardiomyopathy inquired about 
the possibility of combining augmentation mammoplasty using 
the conventional endoscopic approach and CIED insertion un-
der the same subpectoral plane, and we carried out a combina-
tion of these 2 procedures in that patient.
Each patient was informed that the inserted device would re-
quire a battery change every 10 years at the time of battery de-
pletion, and that the same subpectoral plane would be used 
again during each of these future procedures.
We also reviewed all surgical complications that could lead to 
device removal, such as postoperative pain, device migration, 
lead dislodgement, and infection.
Surgical technique
All patients were under general anesthesia throughout the entire 
surgical procedure. In the supine position, the patient’s shoulder 
was abducted to expose the axillary area and the lateral border 
of the pectoralis major muscle. On the axillary fossa, a linear in-
cision approximately 5–7 cm in length was made along one of 
the deepest axillary creases, mostly perpendicular to the lateral 
border of the pectoralis major. Care was taken not to extend this 
incision beyond the anterior axillary fold. The subcutaneous 
dissection proceeded, with undermining remaining close to the 
lateral border of the pectoralis major muscle, since major neuro-
vascular structures are located posteriorly under the axillary fat 
pad. The scrub assistants, if any, should be informed not to re-
tract the lateral tissue too strongly, because this can stretch the 
intercostobrachial nerve and the patient may complain of 
numbness of the upper medial aspect of the affected arm after 
surgery.
When the fascia of the pectoralis major was encountered at its 
lateral border, the submuscular plane was identified while main-
taining intact attachment of the pectoralis minor muscle to the 
chest wall. The clavipectoral fascia enclosing the pectoralis mi-
nor muscle can be readily differentiated from the pectoral fascia 
of the pectoralis major. The dissection continued over the clavi-
pectoral fascia; otherwise, further dissection under the pectora-
lis minor may damage vital structures, such as the thoracoacro-
mial artery, cephalic vein, or lateral pectoral nerve, which may 
appear beyond the muscle. The medial pectoral nerve mainly 
supplies the pectoralis minor and partly the pectoralis major, 
and it may also be exposed and inadvertently damaged during 
undermining. This alone, however, would not result in signifi-
cant functional sequelae. Under the submuscular plane of the 
pectoralis major, dissection is relatively easy without being dis-
turbed by arterial perforators, and the surgeon continued until a 
pocket became large enough to securely receive a cardiac pulse 
generator. Slight upward dissection also exposed an entrance 
window to the subclavian vein, allowing the cardiology team to 
easily gain access to the vein (Fig. 2).
Using the Seldinger technique, the subclavian vein was punc-
tured, and a cardiologist introduced the ventricular lead and, if 
necessary, an atrial lead via a 9-Fr guiding sheath while stably 
anchoring them on the right ventricular apex and right atrial ap-
pendage, respectively. The ventricular and atrial leads were then 
connected to a pulse generator, and device function was evalu-
ated using wireless telemetry with the device in place. The de-
vice was then stably fixed onto either the periosteum of the rib 
bone or the outermost fascia of the intercostalis muscle with ab-
sorbable sutures, and 1 or 2 other additional sutures were made 
into the surrounding tissues (Fig. 3). A negative-pressure drain 
The device is placed inside the subpectoral pocket along the mid-
clavicular level, and is fixated with absorbable sutures onto the 
chest wall. A slight upward dissection provides a window to the 
subclavian vein through which the atrial and ventricular leads are 
introduced.
Fig. 2. Device positioning using the transaxillary approach
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was inserted, and the subcutaneous tissue was repaired in layers, 
first with absorbable sutures and then with nonabsorbable su-
tures for skin closure (Fig. 4).
Blood pressure and other signs of hemodynamics should be 
carefully monitored during the entire procedure, particularly 
while the patient is sitting up for an evaluation of the shape and 
position of the implants.
Postoperative pain was usually not remarkable, and analgesia 
use was similar to or less than that observed in patients who un-
dergo augmentation mammoplasty. We maintained negative-
pressure drains until the daily amount of drainage became less 
than 20 mL.
RESULTS
Cardiac implantable electronic devices 
All patients were treated with subpectoral CIED insertion at a 
single institution by 2 plastic surgeons in collaboration with 3 
cardiologists (Table 1). Four patients received pacemakers, 5 re-
ceived implantable cardioverter defibrillators (ICDs), and 1 pa-
tient was treated with a cardiac resynchronization therapy defi-
brillator.
Patient satisfaction
In general, all patients were highly satisfied with the outcomes. 
They responded with an average of 8.5 points on a scale of 1 to 
10 when asked about how much they were pleased with the 
benefits of the transaxillary procedure. Some patients com-
plained of minor discomfort, such as temporary hypoesthesia 
on and around the incision area. Some did not like the fact that 
they were required to limit their arm movements for the first 
few postoperative weeks. However, all patients said that they 
would recommend this procedure to others of the same age 
with similar cardiac conditions.
Complications
One case of device pocket infection occurred. A bacterial swab 
culture and subsequent blood culture revealed methicillin-resis-
tant Staphylococcus aureus. The device was ultimately surgically 
removed. One month after device removal, when the inflamma-
tion had subsided completely, a new device was inserted into 
the right anterior chest wall using the conventional subcutane-
ous plane.
Another patient experienced mild tingling on the medial as-
pect of the right upper arm, which resolved spontaneously with-
in several weeks. No other significant complications were found 
in the other patients.
DISCUSSION 
As implantable cardioverter defibrillators have become a main-
stay of antiarrhythmic treatments for the primary and secondary 
prevention of sudden cardiac death, providing substantial bene-
fits in terms of utility, efficacy, and safety [1,2,5], several re-
searchers have investigated the quality of life among recipients 
of these devices [6,7]. Moreover, the indications for CIEDs are 
expanding to include younger patients, with the early recogni-
tion of inherited cardiac syndromes, such as long QT syndrome, 
Brugada syndrome, and hypertrophic cardiomyopathy.
Once implanted, CIEDs should be maintained for the rest of 
the patient’s life, and the physical and psychological impact can 
therefore be much greater among young patients. In addition, 
Intraoperative view of an implantable cardioverter-defibrillator 
pulse generator inside the subpectoral pocket placed via the trans-
axillary approach.
Fig. 3. Pulse generator in the subpectoral pocket
Immediate postoperative view after negative-pressure drainage in-
sertion and wound closure. Note that the axillary incision did not 
extend beyond the anterior axillary fold.
Fig. 4. Immediate postoperative view of the axillary area
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these patients will experience psychological discomfort if visible 
scars and bulging of the device are not addressed properly, lead-
ing to a more intense need to alleviate the stigma experienced 
by patients.
The psychosocial impact of CIEDs can be of particular con-
cern, making young female patients most vulnerable. Vazquez re-
ported that younger female patients showed worse perceptions 
of shock anxiety, death anxiety, and body image distress than old-
er female patients [4]. In 2012, Marshall et al. [8] reported that 
female patients were more distressed than male patients about 
the impact of CIEDs on their appearance, especially women 
younger than 39 years of age. Earlier research also revealed that 
younger CIED patients had concerns about various issues, such 
as the fit of clothing, socialization, and sexual activity.
The conventional technique, which involves a subclavian skin 
incision with subcutaneous pocket formation, fails to address 
these quality of life issues. CIED recipients have often been stig-
matized due to the operative scar in the infraclavicular area, 
which is highly susceptible to hypertrophic scarring, because 
unusual tension is applied due to the convexity of the chest wall 
and weight of the breast. The superficial placement of the device 
also involves a greater risk of skin ulceration or device exposure.
 Several alternative surgical approaches, therefore, have been 
suggested in response to these problems. A surgical approach 
through the inframammary fold was the first alternative route 
described in the literature in an effort to place the pacemaker or 
CIED behind the breast tissue or pectoralis major muscle. In 
1983, Belott and Bucko [9] first presented his experience with 2 
female patients utilizing an inframammary approach for pace-
maker placement. Allan [10], in 1985, published a case report 
describing his use of the familiar inframammary approach em-
ployed in augmentation mammoplasty to implant a pacemaker. 
In 1993, Kolettis et al.[11] reported successful retromammary 
CIED device placement with an endocardial lead system in a 
62-year-old woman. These early attempts were done exclusively 
using a subglandular pocket, followed by Ozin et al. [12] and 
Schaverien et al. [13].
Giudici [14] and Collegues [15], in 2001 and 2010, published 
his comprehensive experience with the subpectoral placement 
of pacemakers and CIEDs in 51 female patients over a 9-year 
period. He used the subpectoral plane to place the devices with 
the skin incision on the inframammary fold for device insertion 
and a separate 15–20-mm incision on the anterior axillary line 
for lead insertion. Patient satisfaction was high, and 3 cases of 
lead dislodgement and 1 case of pneumothorax were reported 
as complications. Persichetti also presented, in 2014, 30 consec-
utive female patients who underwent submuscular implantation 
or substitution of CIED devices, which was the largest clinical 
series for submuscular ICD implantation [16]. The inframam-
mary approach leads to excellent cosmetic results, since the op-
erative scar is seen only when the patient raises her arm. Howev-
er, as a 2-incision method, it still requires another skin incision 
in the infraclavicular area for lead insertion and narrow subcuta-
neous tunneling to the device pocket behind the breast.
Other alternative routes include subpectoral placement via a 
conventional infraclavicular incision. In 1992, Hammel et al. 
[17] inserted a CIED under the pectoralis major with a cephalic 
venotomy incision in an obese woman. In 2014, Asamura et al. 
[18] presented results from 21 male patients for the secondary 
replacement of CIED devices; by using the previous operative 
scar in the infraclavicular area, he inserted the devices under the 
pectoralis major muscle by splitting the muscle fibers between 
the clavicular and sternocostal attachment points. Half of the 
patients were lean, with a BMI under 18.5 kg/m2, and the bulge 
from the device became much smoother after the procedure 
than is the case for conventional subcutaneous pockets, al-
though an infraclavicular scar was still obvious.
A skin incision via the lateral border of the pectoralis muscle 
was also utilized by several researchers, particularly among pedi-
atric patients. Molina [19], in 1991, published his long-term ex-
perience with 83 adult female patients and 21 pediatric patients. 
Two skin incisions, a short subclavian puncture and a longer lat-
eral breast incision, were used to insert the device in the sub-
glandular pocket in female patients. Several other reports of 
subpectoral pacemaker insertion for pediatric patients were 
published by Shefer et al. [20] in 1996 and Rosenthal [21] in 
2000, using a direct skin incision along the lateral border of the 
pectoralis major. However, this operative scar on anterior axil-
lary fold was still readily visible upon even slight arm abduction.
Despite the variety of these previous approaches, we believe 
that the transaxillary approach is the most suitable method for 
young female patients. It can effectively conceal the operative 
scar in the axillary fossa, as it can be disguised between natural 
axillary creases, as long as the operator does not extend the inci-
sion anteriorly beyond the anterior axillary fold. The bulge from 
the device is hardly noticeable, allowing the patients to continue 
their normal lives without continuously paying attention to the 
existence of the cardiac device (Fig. 5). This approach may 
eliminate even the small inconveniences in daily life caused by 
the bulge of the device when wearing a seatbelt or carrying a bag 
with shoulder straps. 
The young female patients in our study also showed a high 
level of satisfaction regarding the benefits and outcomes of the 
procedure, and unanimously said that they would recommend 
this transaxillary subpectoral approach to those in similar cir-
cumstances.
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This approach is already time-tested in cosmetic plastic sur-
gery with regard to operative scar management. Moreover, it 
does not necessitate a separate skin incision in the infraclavicular 
area, since the subclavian vein can also be approached via a sin-
gle axillary incision. An additional skin stab incision, no matter 
how short it may be, can be a psychological burden for the pa-
tient if it is located in a potentially visible area.
The transaxillary approach is not regarded as a technically de-
manding task for a plastic surgeon. When performing cosmetic 
augmentation mammoplasty, bleeding from perforators can be 
troublesome given the limited surgical field, but the subpectoral 
pocket for CIED placement is laterally positioned and small, 
such that medial perforators are rarely encountered. Plastic sur-
geons should not find it difficult to implement this transaxillary 
CIED placement procedure, since it is a simpler form of an al-
ready familiar approach, only for a different purpose.
Our first patient experienced bacterial infection inside the de-
vice pocket, and the CIED eventually had to be removed. How-
ever, we encountered no other complications, such as device 
dislocation, lead dislodgement, or pneumothorax. Device dislo-
cation is a very unlikely occurrence, since the device is fixated 
with absorbable sutures tightly onto the chest wall fascia or peri-
Fig. 5. Postoperative results of the transaxillary technique
(A, B) Eight-month postoperative views of a lean 25-year-old female patient (body mass index, 18.37 kg/m2) with hypertrophic cardiomyopathy 
who underwent subpectoral placement of a cardiac implantable electronic device. A slight bulge of the device can be palpated on her left anteri-
or chest wall, but almost unrecognizable by others. (C, D) Flat and linear operative scars can be observed only if the arm is raised well over 90°. (E, 
F) Two-month postoperative chest X-ray images showing no evidence of device migration.
A
D
B
E
C
F
osteum through a separate hole at the corner of the pulse gener-
ator device. Shoulder movement is also restricted for the first 2 
postoperative weeks, leaving the device unaffected by pectoralis 
major muscle contraction, which may potentially dislocate the 
device to an unfavorable position.
The device must be periodically replaced upon battery deple-
tion multiple times throughout the patients’ lives. As the device 
in the subpectoral space sits comfortably inside a fibrous capsule 
by the time it is about to run out of battery, theoretically after 10 
years, battery exchange can be readily performed by opening the 
encapsulated pocket and removing the previous device after 
disconnecting it from the previous leads. The leads can be used 
permanently, so only the pulse generator device should be ex-
changed and functionally tested before reinstallation. The de-
vice pocket is located at approximately the mid-clavicular level, 
so the dissection does not have to be deeper or more extensive 
than the initial procedure.
A transaxillary approach is most appropriate when a lean fe-
male patient is considering augmentation mammoplasty. One 
patient in this study requested a concurrent procedure combin-
ing both CIED placement and augmentation mammoplasty, 
and showed a successful result, with minimal bulging of the de-
Oh JH et al. Transaxillary subpectoral CIED placement
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vice and no additional cardiologic risk. When the procedure is 
combined with augmentation mammoplasty, the surgical ap-
proach is largely identical, as the mammary implants are insert-
ed under the same submuscular plane, but the pocket of the 
breast implant can be distinguished from that of the more supe-
riorly positioned CIED. The pocket dissection should not be 
too extensive compared with the size and shape of the cardiac 
device and breast implant. Otherwise, the breast implant be-
comes susceptible to gradual migration.
Despite the benefits of the transaxillary approach for subpec-
toral placement, not all medical centers may be able to perform 
this procedure, since it requires a certain degree of dedication 
from cardiologists and plastic surgeons alike. For cardiologists, 
the use of a transaxillary approach in the subpectoral plane uti-
lizes a completely different set of procedures, so they should not 
be expected to learn this approach in a center without plastic 
surgeons. This technique can be made possible by the collabora-
tive efforts of dedicated cardiologists and plastic surgeons.
To date, this is the largest clinical series to be published on the 
subpectoral placement of CIEDs via a transaxillary approach, 
which results in superior aesthetic outcomes compared to con-
ventional methods, because this approach is an effective, single-
incision method to obscure operative scars and minimize bulg-
ing of the device. Patients do not have to be aware of the device 
at all times, and they can remain as socially active as before the 
procedure. Young female or lean patients are specific subgroups 
that would benefit the most from this approach.
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